Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tecovirimat is effective against human monkeypox virus in vitro at nanomolar concentrations
Gaelle Frénois-Veyrat, Franck Gallardo, Olivier Gorgé, et al.
Nature Microbiology (2022) Vol. 7, Iss. 12, pp. 1951-1955
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Monkeypox
Natàlia Casamitjana, Dimie Ogoina, Boghuma K Titanji, et al.
The Lancet (2022) Vol. 401, Iss. 10370, pp. 60-74
Open Access | Times Cited: 346
Mpox (formerly monkeypox): pathogenesis, prevention and treatment
Junjie Lu, Hui Xing, Chunhua Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Tecovirimat Resistance in Mpox Patients, United States, 2022–2023
Thomas Smith, Crystal M. Gigante, Nhien T. Wynn, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 12
Open Access | Times Cited: 52
An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses
Jun Wang, Md Shahed-AI-Mahmud, Angelo Chen, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4468-4490
Closed Access | Times Cited: 46
A comprehensive review of monkeypox virus and mpox characteristics
Emmanuel Alakunle, Daniel Kolawole, Diana Diaz-Cánova, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 37
Understanding the biology of monkeypox virus to prevent future outbreaks
Bernard Moss
Nature Microbiology (2024) Vol. 9, Iss. 6, pp. 1408-1416
Closed Access | Times Cited: 22
Structural insights into tecovirimat antiviral activity and poxvirus resistance
Riccardo Vernuccio, Alejandro Martínez León, Chetan Poojari, et al.
Nature Microbiology (2025) Vol. 10, Iss. 3, pp. 734-748
Open Access | Times Cited: 1
Mpox virus infection and drug treatment modelled in human skin organoids
Pengfei Li, Spyridon T. Pachis, Guige Xu, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 2067-2079
Closed Access | Times Cited: 28
Identification and Investigation of a Cryptic Binding Pocket of the P37 Envelope Protein of Monkeypox Virus by Molecular Dynamics Simulations
Parth Sarthi Sen Gupta, Saroj Kumar Panda, Abhijit Kumar Nayak, et al.
The Journal of Physical Chemistry Letters (2023) Vol. 14, Iss. 13, pp. 3230-3235
Closed Access | Times Cited: 26
APOBEC3F Is a Mutational Driver of the Human Monkeypox Virus Identified in the 2022 Outbreak
Rodolphe Suspène, Kyle A. Raymond, Laetitia Boutin, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 10, pp. 1421-1429
Open Access | Times Cited: 26
Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
Yasir Ali, Hina Imtiaz, Tahir Muhammad, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 570-570
Open Access | Times Cited: 22
Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China
Huang Yu, Li Guo, Yanan Li, et al.
Emerging infectious diseases (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 7
Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein
Carolyn Ashley, Emmanuel Broni, Chanyah M. Wood, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 7
Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications
Carmela Pinnetti, Eleonora Cimini, Valentina Mazzotta, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 2, pp. e127-e135
Open Access | Times Cited: 19
Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates
Jérémie Prévost, Angela Sloan, Yvon Deschambault, et al.
Antiviral Research (2024) Vol. 231, pp. 105995-105995
Open Access | Times Cited: 5
“If that would have lessened my symptoms, that would have been great...”: a qualitative study about the acceptability of tecovirimat as treatment for mpox
Sara Paparini, Rosalie Hayes, Ben H. Weil, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Antiviral activity of tecovirimat against monkeypox virus clades 1a, 1b, 2a, and 2b
Jeanne Postal, Florence Guivel‐Benhassine, Françoise Porrot, et al.
The Lancet Infectious Diseases (2025)
Closed Access
Monkeypox: Origin, Transmission, Clinical Manifestations, Prevention, and Therapeutic Options
Sajal Kumar Halder, Arafin Sultana, Mahbubul Kabir Himel, et al.
Interdisciplinary Perspectives on Infectious Diseases (2025) Vol. 2025, Iss. 1
Open Access
Lessons for Medical Countermeasure Development from Unforeseen Outbreaks
Marie Mura, Aurélie Trignol, E. Le Dault, et al.
Emerging Microbes & Infections (2025)
Open Access
Antiviral Effects of Tecovirimat and Cellular Ultrastructural Changes in Human Bronchial Epithelial Cell Line Following Monkeypox Virus Infection
Laura Falasca, Cosmina Mija, Giuseppe Sberna, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2718-2718
Open Access
Isolated Ocular Mpox without Skin Lesions, United States
Tuan M. Nguyen, Akshay Mentreddy, Julie M. Schallhorn, et al.
Emerging infectious diseases (2023) Vol. 29, Iss. 6
Open Access | Times Cited: 13
Temporal intra‐host variability of mpox virus genomes in multiple body tissues
Martina Rueca, Fabio Giovanni Tucci, Valentina Mazzotta, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Open Access | Times Cited: 13
VP37 Protein Inhibitors for Mpox Treatment: Highlights on Recent Advances, Patent Literature, and Future Directions
Shuaibu Abdullahi Hudu, Ahmed Subeh Alshrari, Aiman Al-Qtaitat, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1106-1106
Open Access | Times Cited: 12
Fluorescence-enhanced dual signal lateral flow immunoassay for flexible and ultrasensitive detection of monkeypox virus
Xingsheng Yang, Xiaodan Cheng, Hongjuan Wei, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 12
Identification of the myxobacterial secondary metabolites Aurachin A and Soraphinol A as promising inhibitors of thymidylate kinase of the Monkeypox virus
Yasir Ali, Azmat Ali Khan, Amer M. Alanazi, et al.
Molecular Diversity (2024) Vol. 28, Iss. 5, pp. 3349-3362
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top